HCA Healthcare (HCA) Stock Forecast & Price Target

HCA Healthcare is positioned well because it combines unmatched scale as the largest integrated acute-care provider in the United States with a dominant footprint across 19 states, 190 hospitals, and more than 2,500 outpatient facilities, supporting durable market share and operating leverage. Its outlook is further strengthened by management’s resiliency program across revenue integrity, asset optimization, variable cost management, and fixed cost efficiency, which is expected to improve cost trends sequentially beyond 2Q26 and drive stronger 4Q adjusted EBITDA growth than 3Q. Long-term value creation is also supported by disciplined capital deployment, a $5.0–$5.5 billion 2026 CapEx plan, and expanding outpatient, digital, and clinical capabilities that should cushion exchange headwinds and sustain growth through the balance of 2026.

HCA Healthcare is facing a weakening fundamental setup as incremental healthcare exchange headwinds, payor and service-mix pressure, and softer outpatient and surgical volumes are weighing on core growth. Cost inflation is a major concern, with labor, professional fees, and supplies likely to create outsized margin pressure; management also cited a $180MM EBITDA headwind from first quarter disruptions tied to weather and a soft respiratory season. The company’s heavy dependence on government and managed-care reimbursement, plus intensifying competition and tighter clinical labor supply, leaves 2026 adjusted EBITDA at $15.75B and 2027 adjusted EBITDA at $16.547B exposed to downside risk.